Drugs / SB injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01308645 | Dec 2010 → Dec 2011 | hepatocellular carcinoma | SBPharmaceutical IND, Co., LTD | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SB injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01308645 ↗ |
| Route | Intravenous | “IV route” NCT01308645 ↗ |